PMID: 11337231May 5, 2001Paper

Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia

International Journal of Antimicrobial Agents
M Y KhanZ Memish

Abstract

The incidence of drug resistance in Mycobacterium tuberculosis (MTB) isolated from our hospital between April 1996 and March 1998 was compared with an earlier study (1993-1995). Thirty (29.7%) of 101 MTB isolates were resistant to one or more anti-TB drugs and 21 (20%) of 101 were multi-drug resistant M. tuberculosis (MDR-TB). Resistance was most common to isoniazid (28.7%), followed by streptomycin (22.8%) and rifampicin (20.8%). Resistance to pyrazinamide and ethambutol was 7.9 and 6.9%, respectively. There was a three-fold increase in resistance compared with the earlier study.

References

Jul 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R F Jacobs
Sep 9, 1993·The New England Journal of Medicine·M D Iseman
Oct 2, 2009·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Rana Bokhary

❮ Previous
Next ❯

Citations

Mar 5, 2003·International Journal of Antimicrobial Agents·Hamdan Al-JahdaliDick Menzies
Mar 5, 2003·International Journal of Antimicrobial Agents·Ziad A MemishQanta A Ahmed
Mar 6, 2013·Antimicrobial Agents and Chemotherapy·Sahal Al-HajojZiad Memish
Aug 17, 2005·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Adnan T AbalAlia Al Alawi
Jun 17, 2010·Indian Journal of Pathology & Microbiology·Fawzia Al-Otaibi, Malak M El Hazmi
Feb 16, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J A Al-Tawfiq, Z A Memish
Oct 2, 2012·Journal of Infection and Public Health·Ahmed Morad Asaad, Jobran Miree Alqahtani
Oct 4, 2006·Hemodialysis International·Mohammad AbdelrahmanAyman Karkar
Mar 28, 2006·Lancet·Qanta A AhmedZiad A Memish
Jul 17, 2015·Journal of Chemotherapy·Jaffar A Al-TawfiqZiad A Memish
May 2, 2012·Journal of Chemotherapy·Saber Yezli, Ziad A Memish
Oct 17, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A ShiblZ Memish
Jul 29, 2015·PloS One·Michael G WhitfieldAnnelies van Rie
Dec 29, 2007·PLoS Medicine·Javier ArizaUNKNOWN Institute of Continuing Medical Education of Ioannina
Jul 11, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·H H BalkhyE Tannous
Oct 26, 2018·Circulation·Stephen J GreeneChristopher M O'Connor
Sep 5, 2018·The Journal of International Medical Research·David CarballoDipen Shah
Oct 6, 2020·Frontiers in Public Health·Mohammed Dauda GoniBabagana Mohammed Adam
Sep 21, 2006·Annals of Saudi Medicine·Rupak SinglaM A Shaikh
Dec 13, 2006·Annals of Saudi Medicine·Khaled K Abu-Amero
Sep 10, 2003·Journal of Travel Medicine·Ziad A Memish, Qanta A A Ahmed
Dec 13, 2006·Annals of Saudi Medicine·Abdulrahman A Alrajhi
Apr 2, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Y SammanS Wali

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
F A al-KassimiM N Chowdhury
Archives of Disease in Childhood
A R Gatrad, A Sheikh
BMJ : British Medical Journal
R MacDonald
© 2021 Meta ULC. All rights reserved